- All
- Important
- Financial Update
- Fund Raise
- Board Meeting
- Dividend/Bonus
- JV/Acquisition
- Investor Meet
- Insider Trade
- Pledging
- Others
Supriya Lifescience Limited — Updates, 13-08-2026: Press Release
13-08-2026 | 11:27 pm
13-08-2026 | 11:27 pm
Supriya Lifescience's Q1 FY27 revenue surged 30.8% YoY to 189.75 Cr, though PAT decreased to 24.04 Cr. Key growth drivers include strong export focus, new product commercialization in Anesthetic/ADHD segments, and commissioning of its Ambernath finished dosage facility.
No comments yet. Be the first to comment!